MASS Insider Trading

Insider Ownership Percentage: 27.70%
Insider Buying (Last 12 Months): $178,500.00
Insider Selling (Last 12 Months): $46,488.00

908 Devices Insider Trading History Chart

This chart shows the insider buying and selling history at 908 Devices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

908 Devices Share Price & Price History

Current Price: $4.15
Price Change: Price Decrease of -0.335 (-7.48%)
As of 04/1/2025 03:55 PM ET

This chart shows the closing price history over time for MASS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$4.48Closing price on 03/31/25:

SEC Filings (Institutional Ownership Changes) for 908 Devices (NASDAQ:MASS)

88.06% of 908 Devices stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MASS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$3.81Mbought$4.33MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M-$5M$0$5M$10MTotal InflowsTotal Outflows
908 Devices logo
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Read More on 908 Devices

Today's Range

Now: $4.15
Low: $4.12
High: $4.57

50 Day Range

MA: $3.09
Low: $1.98
High: $4.58

52 Week Range

Now: $4.15
Low: $1.81
High: $7.56

Volume

543,053 shs

Average Volume

948,380 shs

Market Capitalization

$146.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of 908 Devices?

908 Devices' top insider investors include:
  1. Christopher D Brown (Insider)
  2. Kevin J Knopp (CEO)
  3. Joseph H Iv Griffith (CFO)
  4. Michael S Turner (Insider)
Learn More about top insider investors at 908 Devices.